Breaking News Instant updates and real-time market news.

TSRO

Tesaro

$147.24

-1.61 (-1.08%)

12:46
01/11/17
01/11
12:46
01/11/17
12:46

TESARO call volume above normal and directionally bullish

Bullish option flow detected in TESARO with 1,264 calls trading, 1.8x expected, and implied vol increasing almost 2 points to 54.80%. Jan-17 155 calls and Jan-18 110 puts are the most active options, with total volume in those strikes near 540 contracts. The Put/Call Ratio is 0.51. Earnings are expected on February 23rd.

  • 11

    Jan

  • 30

    Jun

TSRO Tesaro
$147.24

-1.61 (-1.08%)

12/27/16
12/27/16
NO CHANGE
Target $151

Outperform
FBR Capital ups TESARO price target to $151
FBR Capital analyst Ed White raised his price target for TESARO to $151 from $133 and keeps the Outperform rating on the shares. The oncology-focused biopharmaceutical company closed Friday up $7.27 to $139.86. TESARO recently announced that the FDA has granted Priority Review for niraparib with a June 30, 2017 action date, White tells investors in a research note. He believes niraparib could be a potential blockbuster PARP inhibitor. Meanwhile, the launch of Varubi continues to "ramp up," with sequential quarter-over-quarter unit growth of 14%, the analyst writes. White says the drug achieved a 28% share of the oral NK-1 market in the U.S. in September.
01/04/17
GABE
01/04/17
NO CHANGE
GABE
Gabelli sees Incyte as more likely target following Gilead hire
Gilead (GILD) is more likely to buy Incyte (INCY) after naming Alessandro Riva to head its Hematology and Oncology Therapeutic unit, Gabelli analyst Jing He tells investors in a research note. Dr. Riva is a Novartis (NVS) veteran while Incyte is led by a team of Novartis veterans and has collaborated with Novartis Oncology on its key drug, Jakafi, the analyst points out. He believes Incyte is "big enough to move the needle" and bring long term growth to Gilead. The analyst lists Seattle Genetics (SGEN) and TESARO (TSRO) as other potential targets for the biotech giant. He believes Incyte is the "best fit."
01/09/17
LEER
01/09/17
NO CHANGE
Target $152
LEER
Outperform
TESARO price target raised to $152 from $115 at Leerink
Leerink analyst Seamus Fernandez raised his price target for TESARO to $152 from $115 to fully incorporate his high expectations for a broad label and reflect niraparib's transformation to a commercial stage asset. The analyst notes that the "strong data" from niraparib's NOVA trial, along with the lack of an expected FDA panel, should result in a broad label in the second-line or greater ovarian cancer maintenance setting, while ongoing niraparib trials in breast cancer and front-line ovarian cancer maintenance and the company's IO platform should be additional potential drivers of upside for the stock. Fernandez sees TESARO as an "attractive takeout target," and reiterates an Outperform rating on the shares.
01/10/17
LEER
01/10/17
NO CHANGE
LEER
Outperform
ARIAD acquisition supports potential takeout premium for TESARO, says Leerink
Leerink analyst Seamus Fernandez says the acquisition of ARIAD (ARIA) by Takeda (TKPYY) for $24 per share appears to be relatively in-line with other commercial stage acquisitions, and supports a potential acquisition price for TESARO (TSRO) of greater than $170 per share based on consensus forecasts. While TESARO remains well positioned to grow independently, the analyst believes a validated PARP inhibitor like niraparib could offer a durable and strategically important product opportunity for multiple suitors. He reiterates an Outperform rating on TESARO's shares.

TODAY'S FREE FLY STORIES

CG

Carlyle Group

$21.10

0.05 (0.24%)

12:00
11/20/17
11/20
12:00
11/20/17
12:00
Hot Stocks
Carlyle Group to acquire BenefitMall, terms not disclosed »

Carlyle Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$93.04

-0.57 (-0.61%)

12:00
11/20/17
11/20
12:00
11/20/17
12:00
Recommendations
AbbVie analyst commentary  »

AbbVie price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYT

New York Times

$17.68

0.025 (0.14%)

11:58
11/20/17
11/20
11:58
11/20/17
11:58
Hot Stocks
New York Times suspends Glenn Thrush following allegations of sexual misconduct »

The New York Times said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
11/20/17
11/20
11:55
11/20/17
11:55
General news
Treasury's $78 B 3- and 6-month bill sale was a little better than average »

Treasury's $78 B 3-…

CBS

CBS

$56.02

-0.72 (-1.27%)

, DISH

Dish

$50.66

0.16 (0.32%)

11:53
11/20/17
11/20
11:53
11/20/17
11:53
Periodicals
CBS: Dish could black out certain programs if pact not reached, Reuters says »

CBS (CBS) warned that…

CBS

CBS

$56.02

-0.72 (-1.27%)

DISH

Dish

$50.66

0.16 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAKE

Cheesecake Factory

$45.44

0.52 (1.16%)

11:50
11/20/17
11/20
11:50
11/20/17
11:50
Options
Cheesecake option volume is 2X daily average as buyers gobble up call options »

Cheesecake option volume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
11/20/17
11/20
11:50
11/20/17
11:50
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

SPY

SPDR S&P 500 ETF Trust

$258.20

0.34 (0.13%)

, SPX

S&P 500

11:48
11/20/17
11/20
11:48
11/20/17
11:48
General news
President Trump says U.S. to designate North Korea a state sponsor of terror »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$258.20

0.34 (0.13%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAH

Cardinal Health

$55.62

-1.89 (-3.29%)

, AMZN

Amazon.com

$1,129.88

-7.41 (-0.65%)

11:44
11/20/17
11/20
11:44
11/20/17
11:44
Hot Stocks
Cardinal Health slides as Morgan Stanley says sell on Amazon risk »

Shares of Cardinal Health…

CAH

Cardinal Health

$55.62

-1.89 (-3.29%)

AMZN

Amazon.com

$1,129.88

-7.41 (-0.65%)

PDCO

Patterson Companies

$36.04

-0.03 (-0.08%)

HSIC

Henry Schein

$69.12

-0.39 (-0.56%)

CVS

CVS Health

$70.02

-0.66 (-0.93%)

WBA

Walgreens Boots Alliance

$71.25

-0.05 (-0.07%)

MCK

McKesson

$138.41

-3.72 (-2.62%)

ABC

AmerisourceBergen

$77.22

-1.625 (-2.06%)

TMO

Thermo Fisher

$190.62

0.45 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 28

    Nov

  • 29

    Nov

  • 30

    Nov

  • 12

    Dec

  • 18

    Mar

TRP

TransCanada

$49.73

0.75 (1.53%)

11:42
11/20/17
11/20
11:42
11/20/17
11:42
Hot Stocks
Nebraska approves TransCanada's Keystone XL pipeline »

The Nebraska Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$17.92

-0.29 (-1.59%)

11:40
11/20/17
11/20
11:40
11/20/17
11:40
Options
GE draws a $2.35M call buyer as shares revisit recent lows »

GE draws a $2.35M call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:40
11/20/17
11/20
11:40
11/20/17
11:40
General news
Euro$ interest rate futures trickled lower »

Euro$ interest rate…

CAVM

Cavium

$75.83

-0.47 (-0.62%)

11:33
11/20/17
11/20
11:33
11/20/17
11:33
Downgrade
Cavium rating change  »

Cavium downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

FCAU

Fiat Chrysler

$17.62

0.255 (1.47%)

11:30
11/20/17
11/20
11:30
11/20/17
11:30
Options
Higher option volume in Fiat driven by longer-term call buying »

Higher option volume in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$46.16

-0.02 (-0.04%)

11:22
11/20/17
11/20
11:22
11/20/17
11:22
Technical Analysis
Technical View: Micron trades to new 52-week highs »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 19

    Dec

XOP

SPDR Oil Exploration and Production Fund

$34.45

-0.55 (-1.57%)

11:20
11/20/17
11/20
11:20
11/20/17
11:20
Options
SPDR Oil Exploration and Production puts active »

SPDR Oil Exploration and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
11/20/17
11/20
11:17
11/20/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
11/20/17
11/20
11:16
11/20/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCK

McKesson

$138.89

-3.24 (-2.28%)

11:15
11/20/17
11/20
11:15
11/20/17
11:15
Options
McKesson put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 29

    Nov

11:15
11/20/17
11/20
11:15
11/20/17
11:15
General news
Treasury announced a $45 B 4-week bill sale for Tuesday »

Treasury announced a $45…

11:15
11/20/17
11/20
11:15
11/20/17
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:15
11/20/17
11/20
11:15
11/20/17
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:14
11/20/17
11/20
11:14
11/20/17
11:14
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

TCO

Taubman Centers

$54.39

-0.92 (-1.66%)

11:12
11/20/17
11/20
11:12
11/20/17
11:12
Rumors
Rumor moving shares of Taubman Centers »

Rumor: Taubman Centers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$20.29

0.03 (0.15%)

11:12
11/20/17
11/20
11:12
11/20/17
11:12
Upgrade
Marvell rating change  »

Marvell upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.